Skip to main content
. 2014 Jul;20(7):1183–1190. doi: 10.3201/eid2007.131587

Figure 2.

Figure 2

Western blot reactivity to recombinant Borrelia miyamotoi glycerophosphodiester phosphodiesterase in serum samples from 5 Borrelia miyamotoi sensu lato�?"seropositive patients in the northeastern United States, 1991�?"2012. Numbers at the top of rows are patient numbers and correspond to patients 26-29 and 45 in Table 1. The letters a and c that follow patient numbers indicate acute- and convalescent-phase serum samples, respectively. Western blot results that show no seroreactive IgG and/or IgM band in acute-phase serum samples and a reactive IgG and/or IgM band in convalescent-phase serum samples are consistent with ELISA results showing a 4-fold rise in B. miyamotoi sensu lato antibody titer from acute-phase (negative) and convalescent-phase (positive) serum samples. The acute-phase serum of patient 28 was nonreactive for IgG in the ELISA assay (Table 1), but the sample was reactive for IgM and IgG on Western blot.